Dr. Sudharani Bairraju

Dr. Sudharani Bairraju brings over two decades of expertise in reproductive medicine, offering evidence-based fertility solutions tailored to each patient's needs. Her approach combines thorough evaluations with advanced treatments to address both male and female infertility. She supports couples throughout their journey with empathy and precision. Her success lies in individualized protocols that optimize conception outcomes.

Having performed over 500 IVF procedures with a commendable success rate, Dr. Sudharani personalizes each IVF cycle based on patient history and ovarian reserve. From stimulation to embryo transfer, every step is meticulously planned. Her expertise ensures higher take-home baby rates and compassionate support throughout the IVF journey.

Dr. Sudharani is adept in all facets of ART, including ICSI, donor programs, and cryopreservation. Her extensive training allows her to integrate the latest techniques with a strong clinical understanding, helping couples with even the most challenging fertility issues achieve positive outcomes.

Dr. Sudharani uses IUI as a first-line treatment for selected infertility cases. She ensures thorough pre-cycle workup, optimal timing, and precise semen processing to maximize pregnancy chances. Her keen focus on patient selection and cycle monitoring improves success rates significantly.

With a postgraduate certification in clinical embryology, Dr. Sudharani oversees each stage of embryo development. She ensures that only the best-quality embryos are transferred or preserved. Her deep understanding of embryology allows her to guide patients through each decision with confidence.

As a fellow in advanced gynecological endoscopy, Dr. Sudharani routinely performs minimally invasive procedures for fibroids, endometriosis, and uterine anomalies. These techniques reduce recovery time, minimize scarring, and improve surgical outcomes, allowing patients a quicker return to daily life.

Dr. Sudharani offers holistic care for menstrual irregularities, PCOS, and hormonal imbalances. Through a blend of diagnostic accuracy, medical management, and lifestyle counseling, she helps women regain hormonal balance and reproductive health. She ensures long-term relief by addressing root causes, not just symptoms.

With years of experience in handling complex pregnancies, Dr. Sudharani ensures safe maternal and fetal outcomes through continuous monitoring and proactive care. She expertly manages conditions like gestational diabetes, hypertension, and multiple pregnancies. Her calm, skilled approach reassures patients during the most delicate phases of their journey to motherhood.

Dr. Sudharani handled critical cases such as ectopic pregnancies, uterine ruptures, and obstructed labor. Her swift decision-making and surgical expertise ensure timely interventions that are often lifesaving. She provides round-the-clock care in emergencies, ensuring patient safety and minimizing complications.

Trained under ISCCP, Dr. Sudharani offers advanced colposcopic evaluations and cervical screening for early detection of abnormalities. Her preventive approach helps in timely diagnosis and treatment of cervical dysplasia, reducing cancer risk. She educates women about HPV vaccination and regular screenings as essential aspects of preventive gynecology.

Female infertility is diagnosed when a woman has not conceived after an appropriate period of regular unprotected intercourse. The causes span a wide spectrum — ovulatory disorders, ovarian reserve decline, tubal blockage, uterine abnormalities, endometriosis, and hormonal imbalances, among others. Dr Sudharani Bairraju provides comprehensive female infertility evaluation at Birthright Fertility by Rainbow Hospitals, Banjara Hills, Hyderabad, beginning with detailed history-taking covering menstrual pattern, lifestyle factors, previous pregnancies, and medical history. Investigation includes pelvic ultrasound with antral follicle count, hormonal profiling (FSH, LH, AMH, TSH, prolactin), and hysterosalpingogram or sonosalpingogram to assess tubal patency and the uterine cavity. Based on findings, treatment may include ovulation induction, intrauterine insemination, laparoscopic management of contributing conditions such as endometriosis, or in vitro fertilisation. With 28 years of experience and 45,000 patients, her approach ensures that every treatment plan is built on an accurate diagnosis rather than assumptions.

Male factor infertility — abnormalities in sperm count, motility, morphology, or other semen parameters — contributes to approximately half of all cases of infertility in couples. Despite this, the male partner is frequently under-investigated in clinical settings. Dr Sudharani Bairraju ensures that semen analysis is a standard and non-negotiable component of every fertility evaluation at Birthright Fertility by Rainbow Hospitals, Banjara Hills, Hyderabad. A baseline semen analysis assesses sperm concentration, total sperm number, progressive motility, morphology, and ejaculate volume. Abnormal results are repeated after four to six weeks before conclusions are drawn. Where a problem is confirmed, further investigation - including hormonal assessment and specialist urology review when indicated - is arranged to identify whether the cause is treatable. Male factor infertility is managed in coordination with appropriate specialists, and in cases where sperm parameters cannot be corrected, assisted reproductive techniques including IUI or IVF with ICSI offer effective pathways to conception.

Male factor infertility, defined as a semen analysis result below the WHO 2021 reference values in one or more parameters, contributes to infertility in approximately half of all couples who have difficulty conceiving, either as the sole factor or in combination with a female factor. The semen analysis is the primary investigation for the male partner and evaluates sperm concentration (lower reference limit 16 million per millilitre), total sperm number (39 million per ejaculate), total motility (42%), progressive motility (30%), and morphology by strict Kruger criteria (4%). A result below the reference limit in one or more of these parameters does not determine the treatment pathway in isolation; it informs it in combination with the degree of the abnormality, which parameters are affected, and the female partner's fertility evaluation. Dr. Sudharani Bairraju, Senior Consultant IVF Specialist at Birthright Fertility by Rainbow Hospitals, Banjara Hills, Hyderabad, with 28 years of fertility practice and Postgraduate Certification in Clinical Embryology and Training in Advanced Infertility and Andrology, evaluates and manages male factor infertility as an integral part of every couple's fertility assessment. A single abnormal semen analysis is never the basis for a treatment decision; the test is always repeated four to six weeks later before conclusions are drawn, because sperm parameters fluctuate naturally and are affected by recent illness, fever, heat exposure, and the interval since the last ejaculation. Where abnormalities are confirmed on repeat testing, hormonal, anatomical, and lifestyle factors are assessed for reversibility before proceeding to assisted reproduction.

The treatment pathway for male factor infertility is determined by the degree and pattern of semen analysis abnormality and the female partner's fertility status, not by a fixed protocol applied to every couple with a low sperm count. Mild male factor abnormalities, where sperm count and motility are below reference limits but not severely reduced, and where the female partner's evaluation is reassuring, may be suitable for intrauterine insemination (IUI), in which a washed and concentrated sperm sample is introduced directly into the uterine cavity at the time of ovulation, increasing the number of motile sperm reaching the fallopian tubes. Moderate male factor abnormalities warrant more careful consideration of whether IUI is appropriate or whether IVF with ICSI offers a significantly better outcome per treatment cycle. Severe male factor abnormalities, including severe oligospermia (very low sperm count), severe asthenospermia (severely reduced motility), or multiple parameter abnormalities simultaneously, indicate IVF with ICSI as the primary treatment approach. Dr. Sudharani Bairraju, Senior Consultant IVF Specialist at Birthright Fertility by Rainbow Hospitals, Banjara Hills, Hyderabad, has transformed the treatment of severe male factor infertility through ICSI, in which a single morphologically normal sperm is selected under high-powered magnification and injected directly into the egg, bypassing entirely the need for the sperm to penetrate the egg independently. ICSI makes biological fatherhood achievable for men with severe sperm abnormalities who would previously have had no viable fertility treatment option, and it is one of the most significant advances in reproductive medicine in the last three decades.